Quick Answer
Vaxart, Inc. reported Net Income Loss of $16.33 million for the year ending 2025.
- Vaxart, Inc. showed an increase of +124.4% in Net Income Loss from 2024 to 2025.
- This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$3.90 million | Q4 2013: -$100.0 thousand | Q1 2014: $3.20 million | Q2 2014: -$10.20 million | Q3 2014: -$6.90 million | Q4 2014: $6.50 million | Q1 2015: $1.20 million | Q2 2015: -$19.90 million | Q3 2015: -$6.60 million | Q4 2015: -$6.50 million | Q1 2016: -$5.20 million | Q3 2016: -$10.00 million | Q4 2016: -$9.10 million | Q1 2017: -$2.80 million | Q2 2017: -$3.54 million | Q3 2017: -$2.17 million | Q4 2017: -$1.08 million | Q1 2018: $2.31 million | Q2 2018: -$8.87 million | Q3 2018: -$6.55 million | Q4 2018: -$4.90 million | Q1 2019: -$1.34 million | Q2 2019: -$5.64 million | Q3 2019: -$5.26 million | Q4 2019: -$6.41 million | Q1 2020: -$1.30 million | Q2 2020: -$8.98 million | Q3 2020: -$8.09 million | Q4 2020: -$13.86 million | Q1 2021: -$16.01 million | Q2 2021: -$16.12 million | Q3 2021: -$17.58 million | Q4 2021: -$20.76 million | Q1 2022: -$25.10 million | Q2 2022: -$29.43 million | Q3 2022: -$29.31 million | Q1 2023: -$25.14 million | Q2 2023: -$22.55 million | Q3 2023: -$17.40 million | Q1 2024: -$24.42 million | Q2 2024: -$16.47 million | Q3 2024: -$14.08 million | Q1 2025: -$15.59 million | Q2 2025: -$14.99 million | Q3 2025: -$8.14 million.
- Over the full 19 years of available data (2009 to 2025), Vaxart, Inc.'s Net Income Loss has grown by 187.2%.
- Historical annual values: Fiscal year 2025: $16.33 million | Fiscal year 2024: -$66.95 million | Fiscal year 2023: -$82.47 million | Fiscal year 2022: -$107.76 million | Fiscal year 2021: -$70.47 million | Fiscal year 2020: -$32.22 million | Fiscal year 2019: -$18.65 million | Fiscal year 2018: -$18.01 million | Fiscal year 2017: -$9.58 million | Fiscal year 2017: -$29.40 million | Fiscal year 2016: -$25.40 million | Fiscal year 2015: -$19.10 million | Fiscal year 2014: -$11.00 million | Fiscal year 2013: -$8.90 million | Fiscal year 2012: -$19.20 million | Fiscal year 2011: -$4.53 million | Fiscal year 2011: -$25.40 million | Fiscal year 2010: $878.0 thousand | Fiscal year 2009: -$18.73 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: